Pharma & HealthcareAvoid

Baroda BNP Paribas Health And Wellness

Baroda BNP Paribas · Direct–Growth · rank #12 of 18 by Smart Score

Compare Source ↗

Trailing returns

vs Nifty 500 (index-fund proxy)

1 Year

5.6%

+5.1% vs index

3 Years

—

5 Years

—

Since launch

6.5%

Year-by-year performance

last entry = YTD

2026

+12.0%+13.7% vs index

Why this score

Baroda BNP Paribas Health And Wellness scores 37/100 — #12 of 18 Pharma & Healthcare fund (Avoid). It stands out for volatility and expense ratio — beating 97% of peers on volatility. The main drag is its sharpe ratio (better than only 3% of peers).

Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.

Sharpe ratio0.00 · 3rd percentile in category

Volatility11.62 · 97th percentile in category

Sortino ratio0.00 · 3rd percentile in category

1Y return5.63% · 9th percentile in category

Expense ratio1.00% · 64th percentile in category

Fund size553.17 Cr · 36th percentile in category

Other Pharma & Healthcare funds

HDFC Pharma And Healthcare

3Y —

SBI Healthcare Opportunities

3Y 24.7%

ICICI Pru Pharma Healthcare And Diagnostics PHD

3Y 25.6%

UTI Healthcare

3Y 26.4%